New drug delivery implant could treat patients remotely
Researchers have developed a new drug delivery system that can be remotely controlled to administer patients with medication.
List view / Grid view
Researchers have developed a new drug delivery system that can be remotely controlled to administer patients with medication.
Researchers have developed a method of creating stable nanoemulsions which could be used in new drug delivery processes.
The latest research and developments from Pharma and Biopharma industry experts.
This in-depth focus looks into industrial workflow processes and also how nature can provide inspiration for drug delivery.
The increasing complexity of formulations and active biological products raises new challenges for pre-filled syringe development. James Mellman, Device Manager at Novartis, speaks to Nikki Withers about the challenges of selecting the right primary packaging for injectable formulations and how he has learnt to expect the unexpected.
In this issue we explore reasons behind critical key drug shortages in the EU, whether viability methods effectively detect all viable organisms and how companies can future-proof their digital technologies ahead of Brexit. Also included are articles on higher order protein structure, FMD compliance and Raman spectroscopy.
Decreased supply of anti-rabies vaccines (ARVs) in Delhi causes outbreak of the disease.
The National Institute for Health and Care Excellence is recommending MSD’s Prevymis (letermovir) within the NHS.
Scientists have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections.
The first platform to facilitate the licensed importation of medical cannabis into Europe has formally launched in the UK.
According to a recent article, drug companies are developing longer-acting, injectable HIV treatments.
JRS Pharma present VIVAPUR MCG and outline the benefits of its formulation for application in nasal sprays.
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded TB Alliance a CETR grant for tuberculosis drug development.
The US Food and Drug Administration (FDA) has approved new treatments for heart disease caused by ATTR-CM in adults.
A new study has found that prices for brand-name prescription drugs averaged 3.2 to 4.1 times higher in the US compared with other countries.